The molecular, biochemical and human pharmacology of thromboxane A₂ in renal diseaseFITZGERALD, G. A; MURRAY, R; PRICE, P et al.Advances in experimental medicine and biology. 1989, Vol 259, pp 325-360, issn 0065-2598, 36 p.Article

Proceedings. II: Pharmacology of platelet inhibition/Symposium on platelet inhibition and vascular occlusion in man, London, England, August 1984Circulation (New York, N.Y.). 1985, Vol 72, Num 6, pp 1163-1225, issn 0009-7322Conference Proceedings

Local anesthetics inhibit thromboxane A₂ signaling in Xenopus oocytes and human K562 cellsHÖNEMANN, Christian W; HAHNENKAMP, Klaus; PODRANSKI, Tobias et al.Anesthesia and analgesia. 2004, Vol 99, Num 3, pp 930-937, issn 0003-2999, 8 p.Article

A novel approach for the study of thromboxane A₂ and prostaglandin H₂ receptors using an ¹²⁵I-labeled ligandHALUSHKA, P. V; MACDERMOT, J; KNAPP, D. R et al.Biochemical pharmacology. 1985, Vol 34, Num 8, pp 1165-1170, issn 0006-2952Article

Inhibition of human platelet thromboxane generation by aspirin in the absence of measurable drug levels in peripheral bloodCERLETTI, C; LATINI, R; DEJANA, E et al.Biochemical pharmacology. 1985, Vol 34, Num 10, pp 1839-1841, issn 0006-2952Article

Anti-thrombotic effect of curcuminSRIVASTAVA, R; DIKSHIT, M; SRIMAL, R. C et al.Thrombosis research. 1985, Vol 40, Num 3, issn 0049-3848, O 413-417Article

Heparin-induced platelet aggregation is inhibited by antagonists of the thromboxane pathwayMIKHAILIDIS, D. P; BARRADAS, M. A; DANDONA, P et al.Thrombosis research. 1986, Vol 42, Num 5, pp 719-720, issn 0049-3848Article

Differences in thromboxane A₂ synthesis by megakaryocytes and plateletsWOJENSKI, C. M; SCHICK, P. K.The Journal of laboratory and clinical medicine. 1991, Vol 118, Num 4, pp 370-376, issn 0022-2143Article

Cardiopulmonary function as related to thromboxane A₂ synthesis in experimental septic shockSCHÜTZER, K.-M; LINDHILM, E; HAGLUND, U et al.Circulatory shock. 1988, Vol 26, Num 1, pp 27-40, issn 0092-6213Article

A possible mechanism of airway hyperresponsiveness induced by prostaglandin F₂α and thromboxane A₂AIZAWA, H; HIROSE, T.Prostaglandins, leukotrienes and essential fatty acids. 1988, Vol 33, Num 3, pp 185-189, issn 0952-3278Article

The effect of thromboxane A₂ synthesis inhibitors on platelet aggregation in whole bloodLAD, N; LUNT, D. O; TUFFIN, D. P et al.Thrombosis research. 1987, Vol 46, Num 4, pp 555-566, issn 0049-3848Article

Thromboxane A₂ induces itch-associated responses through TP receptors in the skin in mice.CommwenteryYOSIPOVITCH, Gil; ANDOH, Tsugunobu; NISHIKAWA, Yumi et al.Journal of investigative dermatology. 2007, Vol 127, Num 8, issn 0022-202X, 1857-1859, 2042-2047 [9 p.]Article

Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A₂ agonist U46619FOULON, I; BACHIR, D; GALACTEROS, F et al.Arteriosclerosis and thrombosis. 1993, Vol 13, Num 3, pp 421-426, issn 1049-8834Article

Cigarette smoking increases thromboxane A₂ formation without affecting platelet survival in young healthy femalesDOTEVALL, A; RÅNGEMARK, C; ERIKSSON, E et al.Thrombosis and haemostasis. 1992, Vol 68, Num 5, pp 583-588, issn 0340-6245Article

Ridogrel inhibits systemic and renal formation of thromboxane A₂ and antagonizes platelet thromboxane A₂/prostglandin endoperoxide receptors upon chronic administration to manWEBER, C; BEETENS, J. R; TEGTMEIER, F et al.Thrombosis and haemostasis. 1992, Vol 68, Num 2, pp 214-220, issn 0340-6245Article

Stimulation of aggregation and trhomboxane A₂ formation of human platelets by hypoxiaPÖNICKE, K; STERNITZKY, R; MEST, H.-J et al.Prostaglandins leukotrienes and medicine. 1987, Vol 29, Num 1, pp 49-59, issn 0262-1746Article

Reversal of thromboxane A₂/prostaglandin H₂ and ADP-induced calcium release in intact plateletsBRACE, L. D; VENTON, D. L; LE BRETON, G. C et al.American journal of physiology. Heart and circulatory physiology. 1985, Vol 18, Num 1, pp H8-H13, issn 0363-6135Article

Thrombopoietin increases platelet sensitivity to α-thrombin via activation of the ERK2-cPLA₂ pathwayVAN WILLIGEN, G; GORTER, G; AKKERMAN, J.-W. N et al.Thrombosis and haemostasis. 2000, Vol 83, Num 4, pp 610-616, issn 0340-6245Article

Thromboxan A₂ und Prophylaxe kardiovaskulärer Erkrankungen = Thromboxane A₂ and prophylaxis of cardiovascular diseaseSCHRÖR, K.Zeitschrift für Kardiologie. Supplementum. 1992, Vol 81, Num 4, pp 185-189, issn 0303-6308Conference Paper

Thromboxane A₂ receptor blockade improves contractile function following cardiopulmonary bypass in dogs and pigsKULATILAKE, N; GONZALEZ-LAVIN, L; GROVER, G. J et al.The Journal of surgical research. 1991, Vol 51, Num 4, pp 336-340, issn 0022-4804Article

Protective effects of the novel thromboxane A₂ receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-10-benzimidazolyl)-ethylidene]-6,11-dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy-9a,11a-epoxymethano-prostaglandin F_2α-induced sudden death in guinea-pigs and ratsSHIRAKURA, S; KARASAWA, A; KUBO, K et al.Arzneimittel-Forschung. 1991, Vol 41, Num 12, pp 1242-1245, issn 0004-4172Article

Interference of eicosapentaenoic and docohexaenoic acids with arachidonate- and U46619-induced platelet activation and desensitizationMOHAMED HATMI; LUSSIANA, J. P; JUNIEN, J. L et al.Biochemical pharmacology. 1988, Vol 37, Num 3, pp 481-489, issn 0006-2952Article

Thromboxane A₂ and prostacyclin release in bleeding time blood during primary haemostasis in healthy individualsTHORNGREN, M; VINGE, E.Acta medica Scandinavica. 1988, Vol 223, Num 2, pp 187-190, issn 0001-6101Article

Prostacyclin and thromboxane A₂ in septic shock: species differencesYELLIN, S. A; NGUYEN, D; QUINN, J. V et al.Circulatory shock. 1986, Vol 20, Num 4, pp 291-297, issn 0092-6213Article

Effects of latamoxef on in vitro and ex vivo thromboxane A₂ generation in human plateletsMIHARA, S; KAKUSHI, H; SHIKE, T et al.Thrombosis research. 1988, Vol 49, Num 2, pp 215-224, issn 0049-3848Article